Hydroxychloroquine and the risk of respiratory infections among RA patients
Objectives To determine the effect of hydroxychloroquine on the incidence of new respiratory infections in a large registry of rheumatoid arthritis (RA) patients compared with a matched cohort receiving other conventional disease-modifying antirheumatic drugs (csDMARDs).Methods We reviewed physician...
Main Authors: | Joel M Kremer, Kevin Winthrop, Dimitrios A Pappas, Jeffrey Greenberg, George Reed, LR Harold, Kevin Kane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/6/3/e001389.full |
Similar Items
-
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine
by: L. Cavagna, et al.
Published: (2002-09-01) -
Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19
by: George G. Zhanel, et al.
Published: (2021-01-01) -
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
by: Siri Lillegraven, et al.
Published: (2019-01-01) -
Hydroxychloroquine‐induced erythema multiforme
by: Dimitra Koumaki, et al.
Published: (2020-03-01) -
Hydroxychloroquine and myasthenia gravis-can one take this risk?
by: Arunmozhimaran Elavarasi, et al.
Published: (2020-01-01)